Mesothelioma diagnosis involves imaging tests (CT scans, PET scans, X-rays), blood tests for biomarkers like mesothelin, and ultimately a tissue biopsy confirmed by pathology. An accurate diagnosis identifies the type of mesothelioma, cell type (epithelioid, sarcomatoid, or biphasic), and stage — all of which determine treatment options and prognosis. The diagnostic process typically takes 2 to 4 weeks from initial imaging to confirmed diagnosis.
Step 1: Imaging Tests
When symptoms suggest a possible chest or abdominal problem, imaging is usually the first diagnostic step. A chest X-ray may reveal pleural effusion or abnormal thickening of the pleura. A CT scan provides detailed cross-sectional images showing tumor location, size, and whether nearby structures are affected. PET scans use radioactive tracers to identify metabolically active cancer cells and help determine if the disease has spread. MRI may be used for additional detail, particularly around the diaphragm and chest wall.
Step 2: Blood Tests and Biomarkers
While no single blood test can definitively diagnose mesothelioma, certain biomarkers can support the diagnosis. Soluble mesothelin-related peptides (SMRP) are elevated in many pleural mesothelioma patients. Fibulin-3 and osteopontin are other biomarkers under study. Blood tests help doctors distinguish mesothelioma from other cancers and monitor treatment response.
Step 3: Biopsy
A tissue biopsy is required for a definitive mesothelioma diagnosis. No imaging test or blood test alone can confirm mesothelioma. Biopsy methods include thoracoscopy (for pleural mesothelioma, a camera is inserted into the chest through a small incision), laparoscopy (for peritoneal mesothelioma, a camera examines the abdominal cavity), and needle biopsy (a less invasive option, though it provides less tissue for analysis).
Step 4: Pathology
The tissue sample is examined by a pathologist — ideally one with experience in mesothelioma — to confirm the diagnosis and determine the cell type. The three cell types are epithelioid (most common, best prognosis), sarcomatoid (most aggressive), and biphasic (a combination of both). Cell type significantly affects treatment recommendations and expected outcomes. Immunohistochemistry tests help distinguish mesothelioma from other cancers with similar cellular appearance.
Why Accurate Diagnosis Matters
An accurate mesothelioma diagnosis is essential for both medical and legal reasons. Medically, the type and cell type determine which treatments are most likely to be effective. Legally, a confirmed mesothelioma diagnosis establishes eligibility for trust fund claims, lawsuits, VA benefits, and other compensation. Patients should seek evaluation at a specialized mesothelioma treatment center where pathologists have experience with this rare cancer.